Cargando…

LIMPRINT in Australia

Background and Study Objective: Australia was one of nine participating countries in the epidemiology Phase II Lymphoedema Impact and Prevalence – International (LIMPRINT) project to determine the number of people with chronic edema (CO) in local health services. Methods and Results: Data collection...

Descripción completa

Detalles Bibliográficos
Autores principales: Gordon, Susan J., Murray, Susie G., Sutton, Trudie, Coulombe, Marie-Michelle, James, Sally J., Van Zanten, Malou, Lawson, Joanne K., Moffatt, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639100/
https://www.ncbi.nlm.nih.gov/pubmed/30995183
http://dx.doi.org/10.1089/lrb.2018.0087
_version_ 1783436402719981568
author Gordon, Susan J.
Murray, Susie G.
Sutton, Trudie
Coulombe, Marie-Michelle
James, Sally J.
Van Zanten, Malou
Lawson, Joanne K.
Moffatt, Christine
author_facet Gordon, Susan J.
Murray, Susie G.
Sutton, Trudie
Coulombe, Marie-Michelle
James, Sally J.
Van Zanten, Malou
Lawson, Joanne K.
Moffatt, Christine
author_sort Gordon, Susan J.
collection PubMed
description Background and Study Objective: Australia was one of nine participating countries in the epidemiology Phase II Lymphoedema Impact and Prevalence – International (LIMPRINT) project to determine the number of people with chronic edema (CO) in local health services. Methods and Results: Data collection occurred through questionnaire-based interviews and clinical assessment with provided LIMPRINT tools. Four different types of services across three states in Australia participated. A total of 222 adults participated with an age range from 22 to 102 years, and 60% were female. Site 1 included three residential care facilities (54% of participants had swelling), site 2 was community-delivered aged care services (24% of participants had swelling), site 3 was a hospital setting (facility-based prevalence study; 28% of participants had swelling), and site 4 was a wound treatment center (specific patient population; 100% of participants had swelling). Of those with CO or secondary lymphedema, 93% were not related to cancer, the lower limbs were affected in 51% of cases, and 18% of participants with swelling reported one or more episodes of cellulitis in the previous year. Wounds were identified in 47% (n = 105) of all participants with more than half of those with wounds coming from the dedicated wound clinic. Leg/foot ulcer was the most common type of wound (65%, n = 68). Conclusions: Distances between services, lack of specialized services, and various state funding models contribute to inequities in CO treatment. Understanding the high number of noncancer-related CO presentations will assist health services to provide timely effective care and improve referral pathways.
format Online
Article
Text
id pubmed-6639100
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Mary Ann Liebert, Inc., publishers
record_format MEDLINE/PubMed
spelling pubmed-66391002019-07-19 LIMPRINT in Australia Gordon, Susan J. Murray, Susie G. Sutton, Trudie Coulombe, Marie-Michelle James, Sally J. Van Zanten, Malou Lawson, Joanne K. Moffatt, Christine Lymphat Res Biol Original Articles Background and Study Objective: Australia was one of nine participating countries in the epidemiology Phase II Lymphoedema Impact and Prevalence – International (LIMPRINT) project to determine the number of people with chronic edema (CO) in local health services. Methods and Results: Data collection occurred through questionnaire-based interviews and clinical assessment with provided LIMPRINT tools. Four different types of services across three states in Australia participated. A total of 222 adults participated with an age range from 22 to 102 years, and 60% were female. Site 1 included three residential care facilities (54% of participants had swelling), site 2 was community-delivered aged care services (24% of participants had swelling), site 3 was a hospital setting (facility-based prevalence study; 28% of participants had swelling), and site 4 was a wound treatment center (specific patient population; 100% of participants had swelling). Of those with CO or secondary lymphedema, 93% were not related to cancer, the lower limbs were affected in 51% of cases, and 18% of participants with swelling reported one or more episodes of cellulitis in the previous year. Wounds were identified in 47% (n = 105) of all participants with more than half of those with wounds coming from the dedicated wound clinic. Leg/foot ulcer was the most common type of wound (65%, n = 68). Conclusions: Distances between services, lack of specialized services, and various state funding models contribute to inequities in CO treatment. Understanding the high number of noncancer-related CO presentations will assist health services to provide timely effective care and improve referral pathways. Mary Ann Liebert, Inc., publishers 2019-04-01 2019-04-17 /pmc/articles/PMC6639100/ /pubmed/30995183 http://dx.doi.org/10.1089/lrb.2018.0087 Text en © Susan J. Gordon et al. 2019; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Gordon, Susan J.
Murray, Susie G.
Sutton, Trudie
Coulombe, Marie-Michelle
James, Sally J.
Van Zanten, Malou
Lawson, Joanne K.
Moffatt, Christine
LIMPRINT in Australia
title LIMPRINT in Australia
title_full LIMPRINT in Australia
title_fullStr LIMPRINT in Australia
title_full_unstemmed LIMPRINT in Australia
title_short LIMPRINT in Australia
title_sort limprint in australia
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639100/
https://www.ncbi.nlm.nih.gov/pubmed/30995183
http://dx.doi.org/10.1089/lrb.2018.0087
work_keys_str_mv AT gordonsusanj limprintinaustralia
AT murraysusieg limprintinaustralia
AT suttontrudie limprintinaustralia
AT coulombemariemichelle limprintinaustralia
AT jamessallyj limprintinaustralia
AT vanzantenmalou limprintinaustralia
AT lawsonjoannek limprintinaustralia
AT moffattchristine limprintinaustralia